Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Immunity
|
September 1, 1995
Reconstitution of invariant chain function in transgenic mice in vivo by individual p31 and p41 isoforms
I Shachar, E A Elliott, B Chasnoff, et al.
Annals of the New York Academy of Sciences
|
January 1, 1991
Characteristics of tachykinin transport vesicles in the optic nerve
P J Morin, R J Johnson, I Shachar, et al.
The Journal of Biological Chemistry
|
November 15, 1993
Different assembly species of IgM are directed to distinct degradation sites along the secretory pathway
E Rabinovich, S Bar-Nun, R Amitay, et al.
Oncogene
|
November 10, 2005
Ha-ras(val12) induces HSP70b transcription via the HSE/HSF1 system, but HSP70b expression is suppressed in Ha-ras(val12)-transformed cells
A Stanhill, V Levin, A Hendel, et al.
Oncogene
|
February 7, 2017
The PTPROt tyrosine phosphatase functions as an obligate haploinsufficient tumor suppressor in vivo in B-cell chronic lymphocytic leukemia
J Wakim, E Arman, S Becker-Herman, et al.
Leukemia
|
October 8, 2004
Grb7 expression and cellular migration in chronic lymphocytic leukemia: a comparative study of early and advanced stage disease
M Haran, S Chebatco, L Flaishon, et al.
The Journal of Experimental Medicine
|
November 9, 2000
Autocrine secretion of interferon gamma negatively regulates homing of immature B cells
L Flaishon, R Hershkoviz, F Lantner, et al.
Inflammatory Bowel Diseases
|
March 12, 2010
CCL2 (pM levels) as a therapeutic agent in Inflammatory Bowel Disease models in mice
N Maharshak, G Hart, E Ron, et al.
Oncogene
|
February 26, 2013
CD84 is a survival receptor for CLL cells
I Binsky-Ehrenreich, A Marom, M C Sobotta, et al.
Oncogene
|
July 26, 2016
CD84 mediates CLL-microenvironment interactions
A Marom, A F Barak, M P Kramer, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Immunity
|
September 1, 1995
Reconstitution of invariant chain function in transgenic mice in vivo by individual p31 and p41 isoforms
I Shachar, E A Elliott, B Chasnoff, et al.
Annals of the New York Academy of Sciences
|
January 1, 1991
Characteristics of tachykinin transport vesicles in the optic nerve
P J Morin, R J Johnson, I Shachar, et al.
The Journal of Biological Chemistry
|
November 15, 1993
Different assembly species of IgM are directed to distinct degradation sites along the secretory pathway
E Rabinovich, S Bar-Nun, R Amitay, et al.
Oncogene
|
November 10, 2005
Ha-ras(val12) induces HSP70b transcription via the HSE/HSF1 system, but HSP70b expression is suppressed in Ha-ras(val12)-transformed cells
A Stanhill, V Levin, A Hendel, et al.
Oncogene
|
February 7, 2017
The PTPROt tyrosine phosphatase functions as an obligate haploinsufficient tumor suppressor in vivo in B-cell chronic lymphocytic leukemia
J Wakim, E Arman, S Becker-Herman, et al.
Leukemia
|
October 8, 2004
Grb7 expression and cellular migration in chronic lymphocytic leukemia: a comparative study of early and advanced stage disease
M Haran, S Chebatco, L Flaishon, et al.
The Journal of Experimental Medicine
|
November 9, 2000
Autocrine secretion of interferon gamma negatively regulates homing of immature B cells
L Flaishon, R Hershkoviz, F Lantner, et al.
Inflammatory Bowel Diseases
|
March 12, 2010
CCL2 (pM levels) as a therapeutic agent in Inflammatory Bowel Disease models in mice
N Maharshak, G Hart, E Ron, et al.
Oncogene
|
February 26, 2013
CD84 is a survival receptor for CLL cells
I Binsky-Ehrenreich, A Marom, M C Sobotta, et al.
Oncogene
|
July 26, 2016
CD84 mediates CLL-microenvironment interactions
A Marom, A F Barak, M P Kramer, et al.
Page
of 2